Article Information
History
- January 30, 2020.
Article Versions
- You are currently viewing Version 1 of this article (January 30, 2020 - 11:48).
- Version 2 (February 4, 2020 - 14:45).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- 1Department of Ecology and Evolutionary Biology, University of California, Irvine, CA 92697, United States
- 2Tata Institute for Genetics and Society, Bangalore, KA 560065, India
- 3Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA 90095, United States
- ↵*AR and VA corresponding authors: aramaiah{at}uci.edu; VArumugaswami{at}mednet.ucla.edu
Posted January 30, 2020.
Insights into Cross-species Evolution of Novel Human Coronavirus 2019-nCoV and Defining Immune Determinants for Vaccine Development
